Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Fertility and Sterility

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.fertnstert.2008.06.016PMID 18692800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.

  2008cited by this paper
• Lack of association between common polymorphisms in the 17beta-hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche.

  2007cited by this paper
• Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome.

  2006cited by this paper
• Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

  2006cited by this paper
• Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature

  2006cited by this paper
• Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.

  2006cited by this paper
• Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth.

  2005cited by this paper
• The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.

  2005cited by this paper
• Conceptualizing human variation

  2004cited by this paper
• Assessing the impact of population stratification on genetic association studies

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

  2004cited by this paper
• Men at risk: occupation and male infertility.

  2004cited by this paper
• Population stratification and spurious allelic association.

  2003cited by this paper
• Family history as a risk factor for the polycystic ovary syndrome.

  2000cited by this paper
• Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome.

  2000cited by this paper
• Heritability and the risk of developing androgen excess.

  1999cited by this paper
• Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women.

  1999cited by this paper
• Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

  1995cited by this paper
• Polycystic ovary syndrome.

  1992cited by this paper
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected

  year unknowncited by this paper

• Genotype and Allele Frequencies of AKR1C3 rs3763676 and rs12529 Variations in a Turkish Population: Novel PCR-RFLP Assays

  2025cites this paper
• 17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease.

  2023cites this paper
• Molecular Mechanisms in the Etiology of Polycystic Ovary Syndrome (PCOS): A Multifaceted Hypothesis Towards the Disease with Potential Therapeutics

  2023cites this paper
• The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis

  2021cites this paper
• Association of genetic polymorphisms with local steroid metabolism in human benign breasts.

  2021cites this paper
• Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome

  2019cites this paper
• Pathophysiological mechanisms of gonadotropins– and steroid hormones–related genes in etiology of polycystic ovary syndrome

  2019cites this paper
• Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology

  2018influential citation
• Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes

  2017cites this paper
• Effect of maternal PCOS and PCOS-like phenotype on the offspring's health.

  2016cites this paper
• Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival

  2015influential citation
• Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)

  2014cites this paper
• Análise de genes moduladores do fenótipo de virilização genital em mulheres com a forma clássica da deficiência da 21-hidroxilase

  2012cites this paper
• 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities

  2012cites this paper
• The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia

  2012cites this paper
• Common genetic aspects between polycystic ovary syndrome and diabetes mellitus.

  2011cites this paper
• Polymorphisms of the HSD17B6 and HSD17B5 Genes in Chinese Women with Polycystic Ovary Syndrome

  2010cites this paper
• KLF15 Is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women.

  2009cites this paper